October 2015

NGO letter to Commissioner Andiukaitis on glyphosate

We are writing to articulate our serious concerns regarding the authorisation renewal assessment report on glyphosate that was produced under the aegis of German authorities and forms the basis for the ongoing peer review by the European Food Safety Authority (EFSA). 2 The WHO’s International Agency for the Research on Cancer (IARC) has classified glyphosate as a “probable carcinogen”.

April 2015

Letter to Commissioner Andriukaitis on the EU response to WHO on Glyphosate

Dear Commissioner Andriukaitis,

The International Agency for Research on Cancer (IARC), the World Health Organisation’s cancer agency, has recently classified the pesticide glyphosate as "probably carcinogenic to humans" (Class 2A). In our view, this designation significantly alters the risk profile associated with the various uses of glyphosate.

April 2015

Letter to Commissioner Andriukaitis on Glyphosate

Concerning : The inclusion of the pesticides Glyphosate and Malathion in the positive list of Regulation 1107/2009.

Dear Commissioner Andriukaitis,

The World Health Organisation’s cancer agency IARC has declared the pesticide Glyphosate and Malathion a “probable human carcinogen”. The IARC reached its decision recently based on the view of 17 experts from 11 countries, who met in Lyon, France, to assess the carcinogenicity of 5 organophosphate pesticides. The IARC’s assessment of the 5 pesticides in its entirety will be published as volume 112 of the IARC Monographs, an overview is already available and is published in the latest issue of The Lancet Oncology (the article is attached to this letter).

July 2014

Letter to Commissioner Borg on Glyphosate

Dear Commissioner Borg,

As you will be very much aware, for many years now there has been much discussion on the adverse effects of the herbicide Glyphosate. An enormous amount of independent academic literature is published on this chemical, summarised in the Annex included in this letter.  Rapporteur Germany, however, keeps on relying solely on the studies submitted by the applicants. This is a strange situation since the applicants have a huge interest in getting “the approval of the active substance”. We therefore need independent studies as a counterbalance to the industry-sponsored studies.

© PAN Europe, Rue de la Pacification 67, 1000, Brussels, Belgium, Tel. +32 2 318 62 55

PAN Europe gratefully acknowledges the financial support from the European Union, European Commission, DG Environment, LIFE programme. Sole responsibility for this publication lies with the authors and the funders are not responsible for any use that may be made of the information contained herein.